chr14-73537686-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001037161.2(ACOT1):c.265C>T(p.Pro89Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00105 in 1,248,094 control chromosomes in the GnomAD database, including 369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00080 ( 29 hom., cov: 19)
Exomes 𝑓: 0.0011 ( 340 hom. )
Consequence
ACOT1
NM_001037161.2 missense
NM_001037161.2 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 2.72
Genes affected
ACOT1 (HGNC:33128): (acyl-CoA thioesterase 1) Enables acyl-CoA hydrolase activity. Involved in acyl-CoA metabolic process; long-chain fatty acid metabolic process; and very long-chain fatty acid metabolic process. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0175803).
BP6
Variant 14-73537686-C-T is Benign according to our data. Variant chr14-73537686-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2357026.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}. Variant chr14-73537686-C-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 29 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACOT1 | NM_001037161.2 | c.265C>T | p.Pro89Ser | missense_variant | 1/3 | ENST00000311148.9 | NP_001032238.1 | |
HEATR4 | NM_001220484.1 | c.-151-7442G>A | intron_variant | ENST00000553558.6 | NP_001207413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACOT1 | ENST00000311148.9 | c.265C>T | p.Pro89Ser | missense_variant | 1/3 | 1 | NM_001037161.2 | ENSP00000311224.4 | ||
HEATR4 | ENST00000553558.6 | c.-151-7442G>A | intron_variant | 2 | NM_001220484.1 | ENSP00000450444.2 |
Frequencies
GnomAD3 genomes AF: 0.000798 AC: 94AN: 117780Hom.: 29 Cov.: 19
GnomAD3 genomes
AF:
AC:
94
AN:
117780
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000897 AC: 145AN: 161716Hom.: 41 AF XY: 0.000854 AC XY: 77AN XY: 90146
GnomAD3 exomes
AF:
AC:
145
AN:
161716
Hom.:
AF XY:
AC XY:
77
AN XY:
90146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00108 AC: 1222AN: 1130252Hom.: 340 Cov.: 29 AF XY: 0.00106 AC XY: 594AN XY: 563012
GnomAD4 exome
AF:
AC:
1222
AN:
1130252
Hom.:
Cov.:
29
AF XY:
AC XY:
594
AN XY:
563012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000798 AC: 94AN: 117842Hom.: 29 Cov.: 19 AF XY: 0.000722 AC XY: 41AN XY: 56800
GnomAD4 genome
AF:
AC:
94
AN:
117842
Hom.:
Cov.:
19
AF XY:
AC XY:
41
AN XY:
56800
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
65
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.265C>T (p.P89S) alteration is located in exon 1 (coding exon 1) of the ACOT1 gene. This alteration results from a C to T substitution at nucleotide position 265, causing the proline (P) at amino acid position 89 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | ACOT1: BP4, BS2; HEATR4: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;T
Sift4G
Benign
T;T
Polyphen
D;.
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at